SciClone Reports 2015 Financial Results

Go back to SciClone Reports 2015 Financial Results

Sciclone Pharma (SCLN) Reports Q4 EPS of $0.30

March 10, 2016 4:41 PM EST

Sciclone Pharma (NASDAQ: SCLN) reported Q4 EPS of $0.30, versus $0.29 reported last year. Revenue for the quarter came in at $42.9 million, versus $41.1 million reported last year.

For earnings history and earnings-related data on Sciclone Pharma (SCLN) click here.

... More